{
    "Trade/Device Name(s)": [
        "TEG 6s Hemostasis System",
        "TEG Manager 2.0.0"
    ],
    "Submitter Information": "Haemonetics Corporation",
    "510(k) Number": "K160502",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140893",
        "K150041"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "April 03, 2017",
    "Summary Letter Received Date": "April 04, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "3.2% citrated tube"
    ],
    "Instrument(s)/Platform(s)": [
        "TEG 6s analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Thrombelastography",
        "Microfluidics"
    ],
    "Methodologies": [
        "Hemostasis analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Accessory",
        "Software",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Haemonetics TEG 6s Hemostasis System and TEG Manager 2.0.0 software accessory for coagulation testing using venous whole blood.",
    "Indications for Use Summary": "In vitro diagnostic use to provide semi-quantitative indications of hemostasis state in adult venous whole blood samples, commonly used in cardiovascular and cardiology procedures to assess hemorrhage or thrombosis before, during, and after procedures.",
    "fda_folder": "Hematology"
}